ACCUSIGN DOA 10,ACCUSIGN DOA PANEL,ACCUSIGN MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP,BIOSIGN DOA 10, BIOSIGN MET/OPI/COC/

High Pressure Liquid Chromatography, Methamphetamine

PRINCETON BIOMEDITECH CORP.

The following data is part of a premarket notification filed by Princeton Biomeditech Corp. with the FDA for Accusign Doa 10,accusign Doa Panel,accusign Met/opi/coc/thc/pcp/bzo/bar/mtd/tca/amp,biosign Doa 10, Biosign Met/opi/coc/.

Pre-market Notification Details

Device IDK983501
510k NumberK983501
Device Name:ACCUSIGN DOA 10,ACCUSIGN DOA PANEL,ACCUSIGN MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP,BIOSIGN DOA 10, BIOSIGN MET/OPI/COC/
ClassificationHigh Pressure Liquid Chromatography, Methamphetamine
Applicant PRINCETON BIOMEDITECH CORP. P.O. BOX 7139 Princeton,  NJ  08543 -7139
ContactJemo Kang
CorrespondentJemo Kang
PRINCETON BIOMEDITECH CORP. P.O. BOX 7139 Princeton,  NJ  08543 -7139
Product CodeLAG  
Subsequent Product CodeDIO
Subsequent Product CodeDIS
Subsequent Product CodeDJG
Subsequent Product CodeDJR
Subsequent Product CodeDKE
Subsequent Product CodeDKN
Subsequent Product CodeDKZ
Subsequent Product CodeLCM
Subsequent Product CodeLFI
CFR Regulation Number862.3610 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-10-06
Decision Date1998-12-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.